Efficacy and Safety of Xialiqi for the Treatment of Benign Prostatic Hyperplasia in a Randomized Trial.

At 8 wk, Xialiqi improved prostate volume, Q max , Q ave , PVR, and IIEF-5 scores in comparison to placebo, although the differences did not reach statistical significance, possibly because of the short therapeutic duration ( Supplementary Table 1 ).

also in 111,027 other papers